Charles River Laboratories Schedules Third-Quarter 2024 Earnings Release and Conference Call
Charles River Laboratories International, Inc. (NYSE: CRL) has announced the schedule for its third-quarter 2024 earnings release and conference call. The company will release its financial results on Wednesday, November 6th, before the market opens. A conference call to discuss the results has been scheduled for the same day at 9:30 a.m. ET.
Investors can access a live webcast of the conference call through the Investor Relations section of the Company's website at ir.criver.com. For those unable to attend the live event, a replay of the webcast will be made available on the same website.
Charles River Laboratories International, Inc. (NYSE: CRL) ha annunciato il programma per il rilascio dei risultati finanziari del terzo trimestre 2024 e la relativa conferenza telefonica. L'azienda renderà noti i propri risultati finanziari mercoledì 6 novembre, prima dell'apertura del mercato. Una conferenza telefonica per discutere i risultati è stata programmata per lo stesso giorno alle 9:30 a.m. ET.
Gli investitori possono accedere a un webcast dal vivo della conferenza telefonica attraverso la sezione Relazioni con gli Investitori del sito web della Società all'indirizzo ir.criver.com. Per coloro che non possono partecipare all'evento in diretta, sarà disponibile una registrazione del webcast sullo stesso sito web.
Charles River Laboratories International, Inc. (NYSE: CRL) ha anunciado el calendario para su publicación de resultados del tercer trimestre de 2024 y la conferencia telefónica. La compañía publicará sus resultados financieros el miércoles 6 de noviembre, antes de la apertura del mercado. Se ha programado una conferencia telefónica para discutir los resultados el mismo día a las 9:30 a.m. ET.
Los inversores pueden acceder a un webcast en vivo de la conferencia telefónica a través de la sección de Relaciones con Inversores del sitio web de la Compañía en ir.criver.com. Para aquellos que no puedan asistir al evento en vivo, estará disponible una repetición del webcast en el mismo sitio web.
찰스 리버 연구소 인터내셔널, Inc. (NYSE: CRL)는 2024년 3분기 실적 발표 및 전화 회의 일정을 발표했습니다. 이 회사는 11월 6일 수요일, 시장 개장 전에 재무 결과를 발표할 것입니다. 결과에 대해 논의하기 위한 전화 회의는 같은 날 오전 9:30 (ET)에 예정되어 있습니다.
투자자들은 회사 웹사이트의 투자자 관계 섹션에서 라이브 웹캐스트를 통해 전화 회의에 접속할 수 있습니다. 실시간 이벤트에 참석할 수 없는 분들을 위해 동일한 웹사이트에서 웹캐스트 재생이 제공될 예정입니다.
Charles River Laboratories International, Inc. (NYSE: CRL) a annoncé le calendrier pour son rapport sur les résultats du troisième trimestre 2024 et la conférence téléphonique. La société publiera ses résultats financiers le mercredi 6 novembre, avant l'ouverture du marché. Une conférence téléphonique pour discuter des résultats est prévue pour le même jour à 9h30 ET.
Les investisseurs peuvent accéder à un webinaire en direct de la conférence téléphonique via la section Relations avec les investisseurs du site Web de la société à l'adresse ir.criver.com. Pour ceux qui ne peuvent pas assister à l'événement en direct, un replay du webinaire sera disponible sur le même site Web.
Charles River Laboratories International, Inc. (NYSE: CRL) hat den Zeitplan für die Veröffentlichung der Ergebnisse des dritten Quartals 2024 und die Telefonkonferenz bekannt gegeben. Das Unternehmen wird seine finanziellen Ergebnisse am Mittwoch, den 6. November, vor Markteröffnung veröffentlichen. Eine Telefonkonferenz zur Diskussion der Ergebnisse ist für denselben Tag um 9:30 Uhr ET angesetzt.
Investoren können über den Bereich für Investor Relations auf der Website des Unternehmens auf ein Live-Webcast der Telefonkonferenz zugreifen unter ir.criver.com. Für diejenigen, die an der Live-Veranstaltung nicht teilnehmen können, wird eine Aufzeichnung des Webcasts auf derselben Website zur Verfügung stehen.
- None.
- None.
Investors will have the opportunity to listen to a live webcast of the conference call through the Investor Relations section of the Company's website at ir.criver.com. A replay will be accessible through the same website.
About Charles River
Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit www.criver.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241016333453/en/
Investor Relations Contact:
Todd Spencer
Corporate Vice President, Investor Relations
781.222.6455
todd.spencer@crl.com
Source: Charles River Laboratories International, Inc.
FAQ
When will Charles River Laboratories (CRL) release its Q3 2024 earnings?
What time is the Q3 2024 earnings conference call for Charles River Laboratories (CRL)?
How can investors access Charles River Laboratories' (CRL) Q3 2024 earnings call?
Will there be a replay available for Charles River Laboratories' (CRL) Q3 2024 earnings call?
